Massive biotech factory for gene therapy could double in size – and help the Covid fight before that
Mayo Pujols, who started mid-pandemic as CEO of Andelyn Biosciences, the gene therapy manufacturing affiliate of Nationwide Children's Hospital, discusses why its massive Columbus facility could double – and why it might play a role in Covid-19 response even before it opens.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Carrie Ghose Source Type: news
More News: American Health | Biotechnology | Children | COVID-19 | Gene Therapy | Genetics | Health Management | Hospitals | Pandemics